News

2021.10.17: Pfizer to Provide Australia with 500,000 Courses of Oral Treatment for COVID-19

2021.05.19: Pfizer Australia transitions to wholesaler distribution model

2021.02.03: Pfizer and BioNTech Achieve Approval by Medsafe For Their Vaccine Against COVID-19

2021.01.25: Pfizer and BioNTech Achieve Approval by TGA for Their Vaccine Against COVID-19

2022.06.01: Review of discount rate in the PBAC guidelines - Phase 2

2022.04.29: Review of discount rate in the PBAC guidelines - Phase 1

2022.02.28: Towards a National Medicines Traceability Framework Consultation Paper

2022.02.18: Cost Recovered Pathway for Medical Services Advisory Committee

2022.01.28: Pfizer Australia 22-23 Pre-Budget Submission

2021.10.22: Pfizer Australia National Medicines Policy Review Submission

Media Enquiries

Accredited journalists can contact the Pfizer Australia & New Zealand Media Relations team at: mediaanz@pfizer.com.

Please note that this email address is intended specifically for journalists with media enquiries and unfortunately, we are unable to respond to any non-media enquiries sent to this address.

PP-UNP-AUS-0006